Related Experiment Video
Updated: Jul 31, 2025

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Cefepime-Induced Neutropenia: A Case Report and Literature Review
Somaya Koraysh1, Junais Koleri2, Maisa Ali2
1Department of Pharmacy, Hamad Bin Khalifa Medical City, Hamad Medical Corporation, Doha, Qatar.
Abstract:
Cefepime is a fourth-generation cephalosporin utilized in treatment of multiple Gram-negative and -positive infections. The current report presents a case of 50-year-old man admitted with epidural abscess who developed neutropenia after prolonged use of cefepime. The neutropenia developed after 24 days of cefepime treatment and resolved 4 days after cessation of cefepime. Assessment of the patient's profile indicated no other possible cause for neutropenia. A literature review was done, and is presented herein to compare and identify the pattern of cefepime-induced neutropenia in 15 patients. The data presented in this article highlight that despite its rarity, cefepime-induced neutropenia should be considered by clinicians when planning a prolonged course of cefepime.
Insights
Prolonged cefepime (a fourth-generation cephalosporin) use can lead to neutropenia, a rare but serious side effect. This condition typically resolves after discontinuing the antibiotic treatment.
Area of Science:
- Pharmacology
- Infectious Diseases
- Hematology
Background:
- Cefepime, a fourth-generation cephalosporin, is widely used for Gram-negative and Gram-positive bacterial infections.
- Neutropenia is a potential adverse effect of various medications, requiring careful monitoring.
- Epidural abscesses necessitate prompt and effective antibiotic therapy.
More Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021